AnalystsInsight

Justin Hauke (Robert W. Baird): Analyst Track Record and Price‑Target Accuracy

How often Justin Hauke’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 245 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Justin Hauke ranks #867 of 1,000 analysts in Exent’s scoring (4.6★).
  • 72.1% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 64 days; 73.5% of calls were up 12 months later.
  • Most‑covered stocks: MTZ, PWR, MYRG, CTOS.
  • Free on Exent: Justin Hauke’s full record, with ratings 3 days after publication.

Justin Hauke’s track record at a glance

Justin Hauke of Robert W. Baird ranks #867 of the 1,000 analysts Exent scores, with a 4.6★ rating and a focus on industrials. Over a 7‑year lookback, 72.1% of Justin’s price targets were reached, 19.7 points above the 52.4% average across all analysts.

MetricJustin HaukeAll analysts
Price‑target hit rate72.1%52.4%
Median days to hit target64 days91 days
Calls up after 12 months73.5%64.0%
Median 12‑month return of calls+28.6%+13.4%
Hit rate, last 2 years89.9%—
Average worst drop after a call−17.6%—
Ratings in the sample245—
Stocks covered6—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetJustin Hauke
Under 30 days29.8%
30–90 days39.3%
90–180 days20.2%
Over 180 days10.7%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Justin Hauke covers most

StockRatings in the sample
MTZ84
PWR84
MYRG70
CTOS60
CTRI26
EME15
HCSG2
IRM2

In the past year Justin’s ratings were 88% Buy, 12% Hold and 0% Sell.

Justin Hauke’s latest ratings

DateStockActionRatingPrice target
Aug 5, 2026CTRIReiterated: BuyBuy$33.00
Aug 4, 2026CTOSReiterated: HoldHold$12.00
Aug 3, 2026MTZReiterated: BuyBuy$363.00
Jul 31, 2026PWRReiterated: BuyBuy$728.00
Jul 31, 2026EMEReiterated: BuyBuy$918.00
Jul 30, 2026MYRGReiterated: BuyBuy$375.00
Jul 27, 2026ITGInitiated Coverage: BuyBuy$19.00
Jul 9, 2026MTZReiterated: BuyBuy$475.00
Jun 18, 2026MTZReiterated: BuyBuy$473.00
Jun 18, 2026MTZMaintained: Buy—$473.00
May 8, 2026CTRIMaintainedBuy$41.00
May 8, 2026CTRIReiterated: BuyBuy$41.00
  • Aug 5, 2026
    Stock
    CTRI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $33.00
  • Aug 4, 2026
    Stock
    CTOS
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $12.00
  • Aug 3, 2026
    Stock
    MTZ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $363.00
  • Jul 31, 2026
    Stock
    PWR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $728.00
  • Jul 31, 2026
    Stock
    EME
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $918.00
  • Jul 30, 2026
    Stock
    MYRG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $375.00
  • Jul 27, 2026
    Stock
    ITG
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $19.00
  • Jul 9, 2026
    Stock
    MTZ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $475.00
  • Jun 18, 2026
    Stock
    MTZ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $473.00
  • Jun 18, 2026
    Stock
    MTZ
    Action
    Maintained: Buy
    Rating
    —
    Price target
    $473.00
  • May 8, 2026
    Stock
    CTRI
    Action
    Maintained
    Rating
    Buy
    Price target
    $41.00
  • May 8, 2026
    Stock
    CTRI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $41.00

Justin’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Justin Hauke’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Justin Hauke ranks #867 of 1,000 with a 4.6★ rating. 72.1% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 73.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Justin Hauke’s success rate is 62.0% by the ranking source and 72.1% by Exent’s price-target hit-rate backtest, with a median of 64 days to reach a target.

Justin Hauke (Robert W. Baird) covers 6 stocks, mostly in industrials. The most frequently rated are MTZ, PWR, MYRG, CTOS, CTRI.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.